Wegovy [Semaglutide] new weight loss drug approved by FDA

U.S. Food and Drug Administration approved the most awaited obesity drug Wegovy which contains Semaglutide 2.4 mg in injection form. As per the U.S. FDA, the medicine is advised once a week for chronic weight loss management. In patients with high B.P., Diabetes type 2, and high cholesterol, this drug is recommended with physical activity. […]

Wegovy [Semaglutide] new weight loss drug approved by FDA Read More »

approved, common side effects, contradictions, dosage, drug, fda, semaglutide, wegovy, weight loss